Immunocytochemical estrogen progestin receptor assays breast cancer monoclonal antibodies Histopathologic demographic biochemical correlations relationship response survival Breast cancer women estrogen receptors ER immunocytochemical assay ICA monoclonal antiestrophilin antibody Sp gamma Results significant correlation biochemical ER determinations tumor grade menopausal status cases results progesterone receptor assay ICA monoclonal anti-PgR antibody KD biochemical PgR measurements ERICA/PgRICA positivity frequent postmenopausal white women Colloid carcinomas likely ERICA positive PgRICA positive whereas medullary carcinomas negative patients advanced mammary carcinoma results ERICA PgRICA response ER PgR dextran-coated charcoal DCC women Stage Stage II breast cancer ERICA disease-free survival Analysis Cox proportional hazard model PgRICA predictor survival disease-free survival women stages disease data ICA predictive prognosis biochemical ER PgR ease ICA performance results method acceptable substitute DCC breast cancers ER/PgR 